LISA CARTER: Open Payments
NPI 1174829634 · BENTON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 45 payments from 7 companies in 2025. Trend: 2023 $643 · 2024 $548 · 2025 $859
Food & beverage: $832Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $178 |
| Neurocrine BioSciences, Inc. | 6 | $141 |
| Lundbeck LLC | 7 | $133 |
| E.R. Squibb & Sons, L.L.C. | 6 | $129 |
| Otsuka America Pharmaceutical, Inc. | 6 | $113 |
| Janssen Pharmaceuticals, Inc | 3 | $103 |
| Supernus Pharmaceuticals, Inc. | 4 | $63 |
Products named: REXULTI, VRAYLAR, INGREZZA, COBENFY, INVEGA SUSTENNA, Qelbree, SPRAVATO.
Industry payments across AR — which companies pay providers there.
